These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2887489)
21. Hepatic hemodynamics and functions in extrahepatic portal obstruction in the rat with liver cirrhosis. Omokawa S; Saitoh H; Arai Y; Itoh M; Furuya T; Asanuma Y; Koyama K Hepatogastroenterology; 1991 Feb; 38(1):56-9. PubMed ID: 2026390 [TBL] [Abstract][Full Text] [Related]
22. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension. Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142 [TBL] [Abstract][Full Text] [Related]
23. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats. Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196 [TBL] [Abstract][Full Text] [Related]
24. Role of gap junctions modulating hepatic vascular tone in cirrhosis. Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605 [TBL] [Abstract][Full Text] [Related]
25. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis. Desmorat H; Vinel JP; Lahlou O; Pipy B; Badia P; Cales P; Combis JM; Souqual MC; Pascal JP Hepatology; 1991 Jun; 13(6):1181-4. PubMed ID: 2050332 [TBL] [Abstract][Full Text] [Related]
26. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis. Jiao LR; Seifalian AM; Habib N; Davidson BR Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637 [TBL] [Abstract][Full Text] [Related]
27. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M; Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709 [TBL] [Abstract][Full Text] [Related]
28. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654 [TBL] [Abstract][Full Text] [Related]
29. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats. Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281 [TBL] [Abstract][Full Text] [Related]
30. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis]. Castaño G; Viudez P; Carlevaro O; Ocampo C; Zandalazini H; Riccitelli M; Sookoian S; Frider B Acta Gastroenterol Latinoam; 1998; 28(4):291-7. PubMed ID: 10347683 [TBL] [Abstract][Full Text] [Related]
31. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Westaby D; Bihari DJ; Gimson AE; Crossley IR; Williams R Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039 [TBL] [Abstract][Full Text] [Related]
32. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver. Shibamoto T; Kamikado C; Koyama S Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271 [TBL] [Abstract][Full Text] [Related]
33. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model. Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788 [TBL] [Abstract][Full Text] [Related]
34. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. Reichen J; Le M J Clin Invest; 1986 Aug; 78(2):448-55. PubMed ID: 3734100 [TBL] [Abstract][Full Text] [Related]
35. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552 [TBL] [Abstract][Full Text] [Related]
36. Arteriovenous shunting in experimental liver cirrhosis in rats. Leehey DJ; Betzelos S; Daugirdas JT J Lab Clin Med; 1987 Jun; 109(6):687-91. PubMed ID: 2884268 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacological lowering of portal pressure in normal rats and in experimental liver cirrhosis]. Altmann O Gastroenterol J; 1991; 51(3-4):142-8. PubMed ID: 1811660 [TBL] [Abstract][Full Text] [Related]
38. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat. Barrowman JA; Granger DN Gastroenterology; 1984 Jul; 87(1):165-72. PubMed ID: 6724260 [TBL] [Abstract][Full Text] [Related]
39. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats]. Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839 [TBL] [Abstract][Full Text] [Related]
40. Effects of total and selective portasystemic shunting on hepatic haemodynamics and some aspects of liver function in the cirrhotic rat. Jenkins SA; Baxter JN; Devitt P; Shields R Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):671-80. PubMed ID: 3802582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]